MedTrace Logo

The Ontario Neurodegenerative Disease Research Initiative

NCT04104373 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 522

Last updated 2024-04-02

No results posted yet for this study

Summary

The Ontario Neurodegenerative Disease Research Initiative (ONDRI) is a province-wide collaboration studying dementia and how to improve the diagnosis and treatment of neurodegenerative diseases including:

* Alzheimer's disease (AD)
* Parkinson's disease (PD)
* amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease)
* frontotemporal lobar degeneration (FTD)
* vascular cognitive impairment, resulting from stroke (VCI)

Conditions

Interventions

OTHER

Observational Cohort

Sponsors & Collaborators

  • Ontario Neurodegeneration Disease Research Initiative

    lead OTHER

Principal Investigators

  • Richard Swartz, MD · Sunnybrook Health Sciences Centre

Eligibility

Min Age
55 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-07
Primary Completion
2018-03-31
Completion
2018-04-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04104373 on ClinicalTrials.gov